Table 9.
Interaction measures between rs7248320 in lncRNA and smoking exposure in lung cancer, NSCLC, lung adenocarcinoma, and lung squamous cell carcinoma
| Measure | Lung cancer
|
NSCLC
|
Lung adenocarcinoma
|
Lung squamous cell carcinoma
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimate | 95% CI | Measure | Estimate | 95% CI | Measure | Estimate | 95% CI | Measure | Estimate | 95% CI | |
| RERI | −0.237 | −1.62 to 1.146 | RERI | 0.121 | −0.872 to 1.114 | RERI | −0.347 | −1.264 to 0.57 | RERI | 2.129 | −1.465 to 5.724 |
| AP | −0.115 | −0.788 to 0.557 | AP | 0.079 | −0.569 to 0.727 | AP | −0.575 | −2.054 to 0.905 | AP | 0.386 | −0.199 to 0.971 |
| S | 0.816 | 0.279 to 2.391 | S | 1.292 | 0.113 to 14.764 | S | 8.086 | 0 to 14588742883.487 | S | 1.893 | 0.476 to 7.524 |
Abbreviations: AP, attributable proportion due to interaction; CI, confidence interval; NSCLC, non-small-cell lung cancer; RERI, relative excess risk due to interaction; S, synergy index.